(Q24246267)

24 July 2017

0 references

1 reference

title

Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients (English)

1 reference

eradication of infectious diseases

24 July 2017

0 references

0 references

1 reference

1 reference

Helicobacter pylori infectious disease

1 reference

4

0 references

Paul Moayyedi

object named as

P Moayyedi

4

0 references

Brendan Delaney

object named as

Brendan Delaney

2

0 references

Alexander C. Ford

1

object named as

Alex C Ford

0 references

author name string

David Forman

3

0 references

A C Ford

1

1 reference

24 July 2017

B C Delaney

2

1 reference

24 July 2017

D Forman

3

1 reference

24 July 2017

publication date

19 April 2006

1 reference

Cochrane Database of Systematic Reviews

24 July 2017

published in

1 reference

24 July 2017

issue

2

1 reference

24 July 2017

page(s)

CD003840

1 reference

Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Long-term effects of eradication of Helicobacter pylori on relapse and histology in gastric ulcer patients: a two-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Short and long term outcome of Helicobacter pylori positive resistant duodenal ulcers treated with colloidal bismuth subcitrate plus antibiotics or sucralfate alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Effects of killing Helicobacter pylori quadruple therapy on peptic ulcer: a randomized double-blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

An alternative non-macrolide, non-imidazole treatment regimen for curing Helicobacter pylori and duodenal ulcers: ranitidine bismuth citrate plus amoxicillin. The RBC H. pylori Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori? A randomized, controlled, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Effect of Helicobacter pylori eradication on duodenal ulcer scar in patients with no clinical history of duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Does treatment of Helicobacter pylori with antibiotics alone heal duodenal ulcer? A randomised double blind placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Cure of duodenal ulcer associated with eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Antibacterial treatment of gastric ulcers associated with Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Successful eradication of Helicobacter pylori prevents relapse of peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease -- results from a randomized trial programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Decision analysis of histamine H2-receptor antagonist maintenance therapy versus Helicobacter pylori eradication therapy: a randomised controlled trial in patients with continuing pain after duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Canadian Helicobacter pylori Consensus Conference update: infections in adults. Canadian Helicobacter Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Summing up evidence: one answer is not always enough.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Review article: clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies: results of a randomized, double-blind, multicenter trial. Gastrointestinal Utilization Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Prospective, randomized, investigator-blind trial of Helicobacter pylori infection treatment in patients with refractory duodenal ulcers. Healing and long-term relapse rates

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Effect of the eradication of Helicobacter pylori on duodenal ulcer healing and ulcer relapse: randomized controlled study in Japan

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Efecto de la erradicación de Helicobacter pylori sobre las lesiones histológicas de la mucosa gástrica a lo largo de 18 meses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Three treatment schemes with colloidal bismuth subcitrate (Q-ULCER) in peptic ulcer with Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Effects of lansoprazole plus amoxycillin on the cure of Helicobacter pylori infection in Japanese peptic ulcer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Comparison of two lansoprazole-antibiotic combinations (amoxycillin or classical triple therapy) for treatment of H. pylori infection in duodenal ulcer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

H2-antagonist maintenance therapy versus Helicobacter pylori eradication in patients with chronic duodenal ulcer disease: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

The effectiveness of omeprazole, clarithromycin and tinidazole in eradicating Helicobacter pylori in a community screen and treat programme

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Double-blind trial of omeprazole and amoxicillin in the cure of Helicobacter pylori infection in gastric ulcer patients. The Ulcer Study Group, Germany

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Ranitidine versus colloidal bismuth subcitrate in combination with amoxicillin and metronidazole for eradicating Helicobacter pylori in patients with duodenal ulcer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Suppression of acid secretion in peptic ulcer disease.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Lansoprazole treatment of Helicobacter pylori-positive peptic ulcers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Lansoprazole Versus Lansoprazole plus Amoxicillin Treatment for Eradication of Helicobacter pylori in Patients with Gastric Ulcer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Effects of lansoprazole with or without amoxicillin on ulcer healing: relation to eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Clinical Efficacy of Lansoprazole in Eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Efficacy of lansoprazole and amoxicillin in eradicating Helicobacter pylori: evaluation using 13C-UBT and Monoclonal H. pylori antibody testing

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Eradication of Helicobacter pylori with Lansoprazole and Clarithromycin in Gastric Ulcer Patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Combination Therapies with a Proton Pump Inhibitor for Helicobacter pylori-Infected Gastric Ulcer Patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Cure of gastric ulcer disease after cure of Helicobacter pylori infection--German Gastric Ulcer Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Eradication of Helicobacter pylori and prevention of recurrence of duodenal ulcer: a randomized, double-blind, multi-centre trial of omeprazole with or without clarithromycin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Triple therapy for the eradication of Helicobacter pylori and reduction of duodenal ulcer relapse: comparison of 1 week and 2 week regimens and recrudescence rates over 12 months

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Ranitidine bismuth citrate with clarithromycin for the eradication of Helicobacter pylori and for ulcer healing

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Bismuth-based triple therapy with bismuth subcitrate, metronidazole and tetracycline in the eradication of Helicobacter pylori: a randomized, placebo controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Treatment of peptic ulcer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Two-year follow-up of duodenal ulcer patients treated with omeprazole and amoxicillin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Prevention of duodenal ulcer recurrence with penicillin. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Long-term follow-up after eradication of Helicobacter pylori with a combination of omeprazole and amoxycillin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

A cost analysis of alternative treatments for duodenal ulcer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003840.PUB4

7 January 2021

10.1002/14651858.CD003840.PUB4

Identifiers

DOI

1 reference

24 July 2017

1 reference